Istvan Juhasz

Summary

Affiliation: University of Debrecen
Country: Hungary

Publications

  1. ncbi request reprint Experiences with the use of povidone-iodine-containing local therapeutics in dermatological surgery and in the treatment of burns: testing for allergic sensitization in postsurgery patients
    Istvan Juhasz
    Department of Dermatology, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary
    Dermatology 204:52-8. 2002
  2. ncbi request reprint Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance
    Mark Barok
    Medical and Health Science Center, Department of Biophysics and Cell Biology, University of Debrecen, 1 Egyetem sqr, Debrecen 4010, Hungary
    Mol Cancer Ther 6:2065-72. 2007
  3. ncbi request reprint Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor
    Mark Barok
    Department of Biophysics and Cell Biology, University of Debrecen, 4012 Debrecen, Egyetem ter 1, Hungary
    Cancer Lett 260:198-208. 2008
  4. ncbi request reprint Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody
    Katalin Goda
    Department of Biophysics and Cell Biology, University of Debrecen, Debrecen, Hungary
    J Pharmacol Exp Ther 320:81-8. 2007
  5. doi request reprint Investigation of micronized titanium dioxide penetration in human skin xenografts and its effect on cellular functions of human skin-derived cells
    Borbala Kiss
    Department of Dermatology, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary
    Exp Dermatol 17:659-67. 2008

Collaborators

  • John W Park
  • Terez Marian
  • Peter Nagy
  • Mark Barok
  • Borbala Kiss
  • Jorma Isola
  • Gyorgy Vereb
  • Janos Szollosi
  • Katalin Goda
  • Balazs I Toth
  • Zsófia Kertész
  • Janos Hunyadi
  • Margit Balazs
  • Tamas Biro
  • Gabriella Czifra
  • Christos C Zouboulis
  • Eniko Toth
  • Andrea Treszl
  • Zita Szikszai
  • Zsuzsa Rakosy
  • Arpád Zoltán Kiss
  • Henrietta Nagy
  • Zoltan Krasznai
  • Gabor Szabo
  • Zsolt Bacso
  • Ferenc Fenyvesi
  • Anita Kapanen
  • Paivikki Kauraniemi
  • Zsuzsanna Pályi-Krekk
  • Minna Tanner
  • Attila Megyeri
  • Miklos Vecsernyes

Detail Information

Publications5

  1. ncbi request reprint Experiences with the use of povidone-iodine-containing local therapeutics in dermatological surgery and in the treatment of burns: testing for allergic sensitization in postsurgery patients
    Istvan Juhasz
    Department of Dermatology, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary
    Dermatology 204:52-8. 2002
    ..An account is made on the adverse effects attributed to Betadine found in the scientific literature, and its use with regard to the proper indications is suggested...
  2. ncbi request reprint Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance
    Mark Barok
    Medical and Health Science Center, Department of Biophysics and Cell Biology, University of Debrecen, 1 Egyetem sqr, Debrecen 4010, Hungary
    Mol Cancer Ther 6:2065-72. 2007
    ..Thus, measuring the ADCC activity of patient's leukocytes against the tumor cells may be a relevant predictor of clinical trastuzumab responsiveness in vivo...
  3. ncbi request reprint Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor
    Mark Barok
    Department of Biophysics and Cell Biology, University of Debrecen, 4012 Debrecen, Egyetem ter 1, Hungary
    Cancer Lett 260:198-208. 2008
    ..Thus, trastuzumab treatment might also be beneficial in the case of patients with breast cancer that is already trastuzumab resistant...
  4. ncbi request reprint Complete inhibition of P-glycoprotein by simultaneous treatment with a distinct class of modulators and the UIC2 monoclonal antibody
    Katalin Goda
    Department of Biophysics and Cell Biology, University of Debrecen, Debrecen, Hungary
    J Pharmacol Exp Ther 320:81-8. 2007
    ..These observations establish the combined application of a class of modulators used at low concentrations and of the UIC2 antibody as a novel, specific, and effective way of blocking Pgp function in vivo...
  5. doi request reprint Investigation of micronized titanium dioxide penetration in human skin xenografts and its effect on cellular functions of human skin-derived cells
    Borbala Kiss
    Department of Dermatology, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary
    Exp Dermatol 17:659-67. 2008
    ....